Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06868615 · ClinicalTrials.gov registry record · NA
AVAVA MIRIA General Use
A NA study of Acne and Wrinkle, sponsored by AVAVA.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06868615 is a NA study of Acne and Wrinkle that is actively recruiting participants, run by AVAVA. The registered enrollment target is 200 participants, above the 135-participant average among 26 other Acne trials with a reported enrollment target (48% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06868615, a NA study of Acne and Wrinkle, is actively recruiting participants, sponsored by AVAVA.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
A general protocol to treat a variety of dermatologic conditions and collect patient feedback. Primary outcome is the collection and analysis of patient questionnaires related to the overall experience of the device treatment. Secondary outcome measures include physician and subject evaluations in regards to improvement seen in the device as well as assessment of side effects.
Conditions Studied
Interventions
- DEVICE AVAVA
Study Locations (1)
Massachusetts
- AVAVA, Inc. - Waltham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-09-11 |
| Est. Completion | 2027-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06868615
The ClinicalTrials.gov registry entry for NCT06868615 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 135-participant average among 26 other Acne trials with a reported enrollment target (48% higher). The listed sponsor is AVAVA, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Acne appearing as the primary indexed condition, and to 1 intervention - of which AVAVA is the first listed.
NCT06868615 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06868615 about?
NCT06868615 is a clinical study titled "AVAVA MIRIA General Use". A general protocol to treat a variety of dermatologic conditions and collect patient feedback. Primary outcome is the collection and analysis of patient questionnaires related to the overall experience of the device treatment. Secondary outcome measures include physician and subject evaluations in ...
What is the current status of trial NCT06868615?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-09-11. Estimated completion is 2027-12-30.
What conditions does trial NCT06868615 study?
This clinical trial studies the following conditions: Acne, Wrinkle, Acne Scars - Mixed Atrophic and Hypertrophic, Scars, Pigment; Lesion.
What interventions are being tested in trial NCT06868615?
The interventions under investigation include: AVAVA (DEVICE).
Who is sponsoring clinical trial NCT06868615?
This trial is sponsored by AVAVA, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06868615 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production
RECRUITING · NA
-
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
RECRUITING · NA
-
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
ACTIVE NOT RECRUITING · NA
-
The Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation
COMPLETED · NA
-
An Exploratory Investigation of a Male Focused Skincare Supplement
COMPLETED · NA
-
An Exploratory Investigation of a Novel Skincare Regimen
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.